TSW
DXR icon

Thompson Siegel & Walmsley’s Daxor DXR Stock Holding History

Thompson Siegel & Walmsley’s Portfolio DXR Stock Details DXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
241,767
+9,647
+4% +$97.5K 0.04% 284
2026
Q1 		$2.25M Buy
+232,120
New +$2.83M 0.04% 279

Other funds holding DXR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Aristides Capital Louisville, Kentucky $514M AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Thompson Siegel & Walmsley's DXR Position: Q2 2026 in Review

Thompson Siegel & Walmsley increased its Daxor (DXR) stake by 4.2% in Q2 2026, buying an estimated $97.5K and bringing the position to 241,767 shares worth $2.49M. The position accounts for 0.04% of the portfolio, ranked #284.

Thompson Siegel & Walmsley first reported a position in DXR in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold DXR as of Q2 2026.

  • Thompson Siegel & Walmsley held 241,767 shares of Daxor worth $2.49M as of Q2 2026.
  • Thompson Siegel & Walmsley bought 9,647 Daxor shares in Q2 2026, an estimated $97.5K.
  • Daxor made up 0.04% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #284 holding.
  • Thompson Siegel & Walmsley first reported a position in Daxor in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Daxor as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.